Company Overview
Company Name
Denali Therapeutics
Address
161 Oyster Point Blvd- South, San Francisco, CA, 94080, United States
Website
dnli.comApprox. Annual Revenue
$36.0M
Employees
200
Established
2001
About Denali Therapeutics
Denali Therapeutics is a biopharmaceutical company based in San Francisco, California, focused on developing treatments for neurodegenerative and lysosomal storage diseases. The company leverages recent scientific advancements to discover and develop effective molecular therapeutics targeting genetic causes and biological processes underlying these debilitating conditions.
Business Profile
Read from the Denali Therapeutics website on Oct 14, 2026. Hover an item to see the exact wording it came from.
About the website
- Website quality (AI-assessed)
- 8/10 · Current copyright notice; Detailed science and pipeline pages
- Footer copyright year
- 2026
Recent changes
What changed on the Denali Therapeutics website and Google listing, as detected by Coldlytics on each visit.
Estimated revenue band moved from $10M-25M to $25M-100M
Coldlytics tracks changes like these across millions of businesses, so you can reach companies the moment they add a pixel, start hiring, or switch software.
Find companies by what just changed →Biotech & Life Sciences Companies near San Francisco, CA
Browse all Biotech & Life Sciences companies in California →
Frequently Asked Questions about Denali Therapeutics
Categories
Technologies Used
Key Decision Makers
Malia Koons Sr. Clinical Trial Manager